Voltar
Revisão Revisado por pares
BIBTEX RIS

Naltrexone, opiate addiction, and endorphins

1982; Wiley; Volume: 2; Issue: 3 Linguagem: Inglês

10.1002/med.2610020302

ISSN

1098-1128

Autores

Mark S. Gold, Charles A. Dackis, A.L.C. Pottash, Harvey H. Sternbach, William J. Annitto, David Martin, Marcy Pasternak Dackis,

Tópico(s)

Receptor Mechanisms and Signaling

Resumo

Medicinal Research ReviewsVolume 2, Issue 3 p. 211-246 Article Naltrexone, opiate addiction, and endorphins Mark S. Gold, Mark S. Gold Fair Oaks Hospital, Summit, New Jersey 07901 Also Psychiatric Diagnostic Laboratories of America, Summit, NJ 07901.Search for more papers by this authorCharles A. Dackis, Charles A. Dackis Fair Oaks Hospital, Summit, New Jersey 07901Search for more papers by this authorA. L. C. Pottash, A. L. C. Pottash Fair Oaks Hospital, Summit, New Jersey 07901 Also Psychiatric Diagnostic Laboratories of America, Summit, NJ 07901.Search for more papers by this authorHarvey H. Sternbach, Harvey H. Sternbach Fair Oaks Hospital, Summit, New Jersey 07901Search for more papers by this authorWilliam J. Annitto, William J. Annitto Fair Oaks Hospital, Summit, New Jersey 07901Search for more papers by this authorDavid Martin, David Martin Psychiatric Diagnostic Laboratories of America, Summit, New Jersey 07901Search for more papers by this authorMarcy Pasternak Dackis, Marcy Pasternak Dackis Rockland Psychiatric Center, Orangeburg, New York 10962Search for more papers by this author Mark S. Gold, Mark S. Gold Fair Oaks Hospital, Summit, New Jersey 07901 Also Psychiatric Diagnostic Laboratories of America, Summit, NJ 07901.Search for more papers by this authorCharles A. Dackis, Charles A. Dackis Fair Oaks Hospital, Summit, New Jersey 07901Search for more papers by this authorA. L. C. Pottash, A. L. C. Pottash Fair Oaks Hospital, Summit, New Jersey 07901 Also Psychiatric Diagnostic Laboratories of America, Summit, NJ 07901.Search for more papers by this authorHarvey H. Sternbach, Harvey H. Sternbach Fair Oaks Hospital, Summit, New Jersey 07901Search for more papers by this authorWilliam J. Annitto, William J. Annitto Fair Oaks Hospital, Summit, New Jersey 07901Search for more papers by this authorDavid Martin, David Martin Psychiatric Diagnostic Laboratories of America, Summit, New Jersey 07901Search for more papers by this authorMarcy Pasternak Dackis, Marcy Pasternak Dackis Rockland Psychiatric Center, Orangeburg, New York 10962Search for more papers by this author First published: July/September 1982 https://doi.org/10.1002/med.2610020302Citations: 73 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 E. J. Simon, J. M. Hiller and I. Edelman, Proc. Natl. Acad. Sci. USA, 70, 1947–1949 (1973). 2 C. B. Pert and S. H. Snyder, Science, 179, 1011–1014 (1973). 3 L. Terenuis, Acta Pharmacol. Toxicol., 33, 377–384 (1973). 4 J. Weijlard and A. E. Erickson, Am. Chem. Soc., 64, 869–870 (1942). 5 L. Lasagna and H. K. Beecher, J. Pharmacol. Exp. Ther., 112, 356–363 (1954). 6 W. R. Martin and C. W. Gorodetzky, J. Pharmacol. Exp. Ther., 150, 437 (1965). 7 L. S. Harris, A. K. Pierson, J. R. Demskinski, and W. L. Dewey, Arch. Int. Pharmacodyn. Ther., 165, 112–126 (1967). 8 A. S. Keats and J. Telford, J. Pharmacol. Exp. Ther., 143, 157–164 (1964). 9 L. Lasagna, T. J. Dekornfeld and J. W. Pearson, J. Pharmacol. Exp. Ther., 144, 12–16 (1964). 10 W. R. Martin, H. F. Fraser, C. W. Gorodetzky, and D. E. Rosenberg, J. Pharmacol. Exp. Ther., 150, 426–429 (1965). 11 W. R. Martin, C. W. Gorodetzky, and T. K. McClaine, Clin. Pharmacol. Ther., 7, 455–458 (1966). 12 F. F. Foldes, J. N. Lunn, J. Moore, and I. M. Brown, Am. J. Med. Sci., 245, 23–30 (1963). 13 A. Zaks, T. Jones, M. Fink, and A. M. Freedman, J. Am. Med. Assoc., 215, 2108–2110 (1971). 14 S. Archer, NIDA Research Monograph, 28 (1980). 15 H. Blumberg, I. J. Pachter, and Z. Matossiank, U.S. Pat. 3,332,950 (July 25, 1967). 16 W. R. Martin, D. R. Jasinski, and P. A. Mansky, Arch. Gen. Psychiat., 28, 784–791 (1973). 17 H. Blumberg and H. B. Dayton, in Narcotic Antagonists, M. C. Braude, L. S. Harris, E. L. May, J. P. Smith, and J. E. Villarreal, Eds., Raven, New York, 1974. 18 W. R. Martin and D. R. Jasinski, Clin. Pharmacol. Ther., 14, 142 (1973). 19 H. W. Kosterlitz and A. J. Watt, Report to the Committee on Problems of Drug Dependence, published in the proceeding of the 30th meeting held in Indianapolis, IN, 1968. 20 H. Blumberg and H. B. Dayton, in Agonist and Antagonist Actions of Narcotic Analgesic Drugs, H. W. Kosterlitz, H. O. J. Collier, and J. E. Villarreal, Eds., MacMillan, New York, 1973. 21 K. Verebey, NIDA Research Monograph, 28, 147–160 (1980). 22 M. Perez-Reyes and M. E. Wall, NIDA Research Monograph, 28, 93–104 (1980). 23 K. Verebey, J. Volavka, S. J. Mule and R. B. Resnick, Clin. Pharmacol. Ther., 20, 315–328 (1976). 24 A. L. Misra, NIDA Research Monograph, 28, 132–147 (1980). 25 M. E. Wall, D. R. Brine and M. Perez-Reyes, NIDA Research Monograph, 28, 105–131 (1981). 26 K. Verebey and S. J. Mule, Am. J. Drug Alcohol Abuse, 2, 357–363 (1975). 27 E. J. Cone, Tetrahedron Lett., 28, 2607–2610 (1973). 28 S. H. Snyder, N. Engl. J. Med., 296, 266–271 (1977). 29 D. V. Reynolds, Science, 164, 444–445 (1969). 30 D. J. Mayer, T. L. Wolfe, H. Akil, B. Carder, and J. C. Liebeskind, Science, 174, 1351–1354 (1971). 31 W. R. Martin, C. G. Eades, J. A. Thompson, R. E. Huppler, and P. E. Gilbert, J. Pharmacol. Exp. Ther., 197, 517–532 (1976). 32 W. R. Martin, Life Sci., 28, 1547–1554 (1981). 33 J. Hughes, Brain Res., 88, 295–308 (1975). 34 G. W. Pasternak, R. Goodman, and S. H. Snyder, Life Sci., 16, 1765–1769 (1975). 35 L. Terenius and A. Wahlstrom, Acta Physiol. Scand., 94, 74–81 (1975). 36 J. Hughes, T. W. Smith, H. W. Kosterlitz, L. A. Fothergill, B. A. Morgan, and H. R. Morris, Nature, 258, 577–579 (1975). 37 A. F. Bradbury, D. G. Smyth, C. R. Snell, N. J. M. Birdsall, and E. C. Hulme, Nature, 260, 793–795 (1976). 38 C. H. Li and D. Chung, Proc. Natl. Acad. Sci. USA, 73, 1145–1148 (1976). 39 B. M. Cox, D. Goldstein and C. H. Li, Proc. Natl. Acad. Sci. USA, 73, 1821–1823 (1976). 40 H. H. Loh, L. F. Tseng, E. Wei, and C. H. Li, Proc. Natl. Acad. Sci. USA, 73, 2895–2898 (1976). 41 R. E. Mains, B. A. Eipper and N. Ling, Proc. Natl. Acad. Sci. USA, 74, 3014–3018 (1977). 42 J. L. Robert and E. Herbert, Proc. Natl. Acad. Sci. USA, 74, 4826–4830 (1977). 43 S. Nakonishi, A. Inoue, S. Taii, and S. Numa, FEBS Lett., 88, 105–109 (1977). 44 P. Crine, C. Gianoulakis, N. G. Seidal, F. Gossard, P. D. Penzalla, M. Lis, and M. Chretien, Proc. Natl. Acad. Sci. USA, 75, 4719–4723 (1978). 45 E. Weber, R. Martin, and K. H. Voigt, Life Sci., 25, 1111–1118 (1979). 46 E. Weber, K. H. Voigt, and R. Martin, Brain Res., 157, 385–390 (1978). 47 T. Kita, A. Inoue, S. Nakanishi, and S. Numa, Eur. J. Biochem., 93, 213–220 (1979). 48 R. Guillemin, T. Vango, and J. Rossler, Science, 197, 1367–1369 (1977). 49 R. Simantov, M. J. Kuhar, G. Uhl, and S. H. Snyder, Proc. Natl. Acad. Sci. USA, 74, 467–471 (1977). 50 M. W. Adler, Life Sci., 26, 497–510 (1980). 51 S. H. Snyder and S. R. Childers, Ann. Rev. Neurosci., 2, 35–64 (1979). 52 S. J. Watson, J. D. Barchas and C. H. Li, Proc. Natl. Acad. Sci. USA, 74, 5155–5158 (1977). 53 S. H. Snyder, Am. J. Psychiat., 135, 6 (1978). 54 M. S. Gold, A. L. C. Pottash, Adv. Alcohol Substance Abuse, 1, 33–53 (1981). 55 D. H. Clouet and J. P. O'Callaghan, Adv. Biochem. Psychopharmacol., 20, 281–300 (1979). 56 E. L. Way, Adv. Biochem. Psychopharmacol., 20, 3–27 (1979). 57 T. M. Cho, P. Y. Law, and H. H. Loh, Adv. Biochem. Psychopharmacol., 20, 69–101 (1979). 58 D. H. Ross, H. L. Cardenas, Adv. Biochem. Psychopharmacol., 20, 301–336 (1979). 59 P. Cushman, Adv. Alcohol Substance Abuse, 1, 77–99 (1981). 60 J. W. Holaday and H. H. Loh, Adv. Biochem. psychopharmacol., 20, 227–258 (1979). 61 G. Tolis, J. Hickey, and H. Guyda, J. Clin. Endocrinol. Metab., 41, 797–800 (1975). 62 H. D. Kleber and M. S. Gold, Ann. N.Y. Acad. Sci., 311, 81 (1978). 63 C. W. Rivier, M. Vale, M. Brown, and R. Guillemin, Endocrinology, 100, 238 (1977). 64 E. L. Lien, R. L. Fenischel, V. Garsky, D. Sarantakis, and N. H. Granat, Life Sci., 19, 837 (1976). 65 J. Rossier, E. Battenberg, Q. Pittman, A. Bayon, L. Koda, and R. Miller, Nature, 277, 653–655 (1979). 66 S. L. Wardlaw, W. B. Wehrenberg, M. Ferin, and A. G. Frantz, Endocrinology 170, 1663–1666 (1980). 67 C. J. Shaar, R. C. A. Frederickson, N. B. Dininger, and L. Jackson, Life Sci., 21, 853 (1977). 68 M. S. Gold, D. E. Redmond, and R. K. Donabedian, Lancet, 1, 323–324 (1978). 69M. S. Gold, D. E. Redmond, and R. K. Donabedian, Endocrinology, 105, 284–289 (1979). 70 M. S. Gold, D. R. Sweeney, A. L. C. Pottash, and H. D. Kleber, Am. J. Psychiat., 136, 849–850 (1979). 71 M. S. Gold, A. L. C. Pottash, L. B. Finn, H. D. Kleber and I. Extein, Psychiat. Res., 2, 205–210 (1980). 72 H. Lal, W. Brown, R. Drawbaugh, M. Hynes, and G. Brown, Life Sci., 20, 101–106 (1977). 73 L. Ferland, K. Fuxe and P. Enoroth, Eur. J. Pharmacol., 43, 89 (1977). 74 J. Meites and J. A. Clemens, Vitam. Horm. (Leipzig), 30, 165 (1972). 75 A. G. Frantz, N. Engl. J. Med., 298, 201 (1978). 76 G. Tolis, Hosp. Pract., 15, 85–100 (1980). 77 W. A. Stubbs, A. Jones, C. R. W. Edwards, and G. Delitola, Lancet, 2, 1225–1227 (1978). 78 L. Grandison, W. Fratta, and A. Guidotti, Life Sci., 26, 1633–1642 (1980). 79 J. E. Morley, N. G. Baranetsky, and T. D. Wingert, J. Clin. Endocrinol. Metab., 50, 251–257 (1980). 80 J. H. Mendelson, J. Ellingboe, J. Kuehnle, and N. K. Mello, Psychoneuroendocrinology, 3, 231–236 (1979). 81 J. H. Mendelson, J. E. Mendelson, and V. D. Patch, J. Pharmacol. Exp. Ther., 192, 211–217 (1975). 82 T. J. Cicero, R. D. Bell, and W. G. Wiest, N. Eng. J. Med., 292, 882–887 (1975). 83 P. Cushman, Am. J. Med., 55, 452–458 (1973). 84 P. Cushman, N.Y. State J. Med., 72, 1261–1265 (1972). 85 J. H. Mendelson and N. K. Mello, Clin. Pharmacol. Ther., 17, 529–533 (1975). 86 J. H. Mendelson, J. Ellingboe, J. C. Kuehnle, and N. K. Mello, NIDA Research Monograph, 27, 302–308 (1979). 87 F. Szizi, A. G. Vagenakis, C. Longcope, S. H. Ingbar, and L. E. Braverman, Steroids, 22, 467–472 (1973). 88 S. S. Stoffer, Am. J. Obstet. Gynecol., 101, 770–783 (1968). 89 D. H. Catlin, R. E. Polant, D. A. Gorelick, R. H. Gerner, K. K. Hue, R. T. Rubin, and C. H. Li, J. Clin. Endocrinol. Metab., 41, 797–800 (1975). 90 J. E. Morley, N. G. Baranetsky, and H. E. Carlson, The Endocrine Society Program of 60th Annual Meeting, 25 (1978). 91 E. Weber, R. Martin and K. H. Voigt, Life Sci., 25, 1111–1118 (1979). 92 R. Guillemin, T. Vargo, J. Rossier, S. Minick, N. Ling, C. Rivier, W. Vale, and F. Bloom, Science, 197, 1367–1369 (1977). 93 S. L. Sabor, Biochem. Biophys. Res. Commun., 82, 560–567 (1978). 94 P. W. Gold, I. Extein, D. Pickar, R. Rebar, R. Ross, and F. K. Goodwin, Am. J. Psychiat., 137, 862–863 (1980). 95 J. H. Mendelson, R. E. Meyer, J. Ellingboe, S. M. Mirin, and M. McDougle, J. Pharmacol. Exp. Ther., 195, 296–302 (1975). 96 M. S. Gold, A. L. C. Pottash, I. Extein, H. D. Kleber, Lancet, 2, 973 (1980). 97 J. Volavka, C. Dong and A. Mallya, N. Engl. J. Med., 300, 1056–1057 (1979). 98 H. Lehmann, N. P. V. Nair and N. S. Kline, Am. J. Psychiat., 136, 762–766 (1979). 99 W. W. K. Ho, H. L. Wen, K. P. Fung, Y. H. Ng, K. K. Au, and L. Ma, Clin. Chem. Acta, 75, 415–419 (1977). 100 V. Hollt, R. Przewlocki, and A. Herz, Life Sci., 23, 1057–1066 (1978). 101 E. J. Sachar, L. Hellman, F. J. Roffwarg, F. S. Halpern, D. K. Fukushimp, and T. F. Gallagher, Arch. Gen. Psychiat., 28, 19–24 (1973). 102 R. Dent and G. Tolis, 58th Annual Endocrine Society Meeting 217 (1976). 103 J. B. Webster, J. J. Coupal, and P. Cushman, J. Clin, Endocrinol. Metab., 37, 928–934 (1973). 104 E. Eidelberg, Prog. Neurobiol., 6, 81–102 (1976). 105 H. Lal, Life Sci., 17, 483–496 (1975). 106 D. C. S. Roberts, S. Mason, and H. C. Fibiger, Eur. J. Pharmacol., 52, 209–214 (1978). 107 S. J. Bird, S. F. Atweh, and M. J. Kuhar, Opiates and Endogeneous Peptides, H. Kosterlitz, Ed., Elsevier, Amsterdam, 1976, pp. 199–204. 108 J. P. Fry, A. Herz, and W. Zieglgansberger, Br. J. Pharmacol., 68, 585–592 (1980). 109 A. Herz, J. Blasig, and R. Papeschi, Psychopharmacologia, 39, 121–143 (1974). 110 J. Korf, B. S. Bunney, and G. K. Aghajanian, Eur. J. Pharmacol., 25, 165–169 (1974). 111 M. J. Kuhar, Ann. N.Y. Acad. Sci., 311, 35–48 (1978). 112 F. E. Bloom, J. Rossier, E. L. Battenberg, A. Bayon, E. French, S. J. Hendricksen, G. R. Siggins, D. Segal, R. Browne, N. Ling, and R. Guillemin, Adv. Biochem. Psychopharmacol., 18, 89–109 (1978). 113 S. J. Watson, H. Akil, S. Sullivan, and J. D. Barchas, Life Sci., 21, 733–738 (1977). 114 C. B. Pert, M. J. Kuhar, S. H. Snyder, Life Sci., 16, 1849–1954 (1975). 115 S. F. Atweh, and M. J. Kuhar, Brain Res., 129, 1–12 (1977). 116 T. H. Svensson, B. S. Bunney, G. K. Aghajanian, Brain Res., 92, 291–306 (1975). 117 J. M. Cedarbaum and G. K. Aghajanian, Brain Res., 112, 413–419 (1976). 118 J. M. Cedarbaum and G. K. Aghajanian, Eur. J. Pharmacol., 44, 375–385 (1977). 119 J. M. Cedarbaum and G. K. Aghajanian, Neurosci. Abstr., 2, 683 (1976). 120 D. A. Greenberg, D. C. U'Prichard, and S. H. Snyder, Life Sci., 19, 69–76 (1976). 121 H. Schmitt, M. M. E. H. Schmitt, and S. Fenard, Eur. J. Pharmacol., 14, 98–100 (1971). 122 K. Starke, Rev. Physiol. Biochem. Pharmacol., 77, 1–124 (1977). 123 L. Bertilsson, K. Haglund, J. Ostman, M. D. Rawlins, V. A. Ringberger, and F. Sjoqvist, Eur. J. Clin. Pharmacol., 11, 125–128 (1977). 124 U. Strombom, Acta. Physiol. Scand., 431, 1–43 (1975). 125 T. Suda, A. S. Liotta, and D. T. Krieger, Science, 202, 221–223 (1978). 126 L. Lasagna, J. M. von Felsinger, and H. K. Beecher, J. Am. Med. Assoc., 157, 1006–1020 (1955). 127 A. Wilker, Opinoid Dependence Mechanisms and Treatment, Plenum, New York, 1980, Vol. 7, pp. 167–218. 128 T. Thompson and W. Ostlund, J. Comp. Physiol. Psychol., 59, 388–392 (1965). 129 C. P. O'Brien, Pharmacol. Rev., 27, 533–543 (1976). 130 C. P. O'Brien, R. Greenstein, J. Ternes, A. T. McLellan, and J. Grabowski, Problems of Drug Dependence, Proceedings of the 41st Annual Scientific Meeting of the Committee on Problems of Drug Dependence, Inc., Philadelphia, PA, June 4–6, 1979. 131 A. Wikler, NIDA Research Monograph, 9, 119–122 (1976). 132 A. Wikler, Adv. Biochem. Pharmacol., 8, 399–414 (1974). 133 J. D. Teasdale, Int. J. Addict., 8, 273–292 (1973). 134 W. R. Martin and D. R. Jasinski, J. Psychiat. Res., 1, 9–17 (1969). 135 R. Meyer, M. Randall, C. Barrington, S. Mirin, and I. Greenberg, NIDA Research Mongraph, 9, 123–135 (1976). 136 P. F. Renault, NIDA Research Monograph, 28, 11–24 (1980). 137 P. F. Renault, NIDA Research Monograph, 19, 340–345 (1978). 138 M. Thomas, M. Kanders, M. Harris, J. Cooperstein, G. Hough, and R. Resnick, NIDA Research Monograph, 9, 88–92 (1976). 139 R. H. Reuning, S. H. T. Lias and A. E. Straubus, NIDA Research Monograph, 28, 172–184 (1980). 140 A. C. Sharon and D. L. Wise, NIDA Research Monograph, 28, 194–213 (1980). 141 L. Malspeis, M. S. Bathaza, R. M. Ludden, H. B. Bhat, S. G. Frank, T. D. Sokoloski, B. E. Morriston, and R. H. Reuning, Res. Commun. Chem. Pathol. Pharmacol., 12, 43–65 (1975). 142 K. Verebey, M. J. Kogan, A. DePace, and S. J. Mule, J. Chromatogr., 118, 331–335 (1976). 143 E. J. Cone, C. W. Gorodetzky, and S. Y. Yeh, Drug Metab. Dispos., 2, 506–512 (1974). 144 J. A. Thornhill, M. Hirst, and C. W. Gowdey, Can. J. Psyiol. Pharmacol., 56, 483–489, (1978). 145 R. Burkhardt and G. Peters, 7th International Congress on Pharmacology, Paris, p. 177 (1978). 146 F. S. Tepperman, M. Hirst, and C. W. Gowdey, Life Sci., 28, 2459–2467 (1981). 147 S. Grandison and A. Guidiotti, Neuropharmacology, 16, 533–536 (1977). 148 J. E. Morley and A. S. Levine, Life Sci., 29, 1901–1903 (1981). 149 J. D. Belluzi and L. Stein, Neurosci. Abstr., 8, 405 (1978). 150 J. E. Morley and A. S. Levine, Life Sci., 27, 264–274 (1980). 151 J. E. Morley, A. S. Levine, S. S. Murray, and J. Kneip, Endocrinology, 108, 884A (1981). 152 D. L. Margules, B. Moisset, M. J. Lewis, H. Shibuya and C. B. Pert, Science, 202, 988–991 (1978). 153 S. R. Gambert, T. L. Garthwaite, C. H. Pontzer, and T. C. Hagen, Science, 210, 1271–1272 (1980). 154 S. G. Holtzman, J. Pharmacol. Exp. Ther., 189, 51–60 (1974). 155 D. R. Brown and S. G. Holtzman, Pharmacol. Biochem. Behav., 11, 567–573 (1979). 156 B. Brands, J. A. Thornhill, M. Hirst, and C. W. Gowdey, Life Sci., 24, 1773–1778 (1979). 157 H. Frenk and G. H. Rogers, Behav. Neurol. Biol., 26, 23–40 (1979). 158 J. E. Morley and A. S. Levine, Science, 209, 1259–1261 (1980). 159 M. T. Lowy and G. K. W. Yim, Neuropharmacol., 20, 883–886 (1981). 160 O. Trygstad, I. Foss, and P. Edminson, Acta Endocrinol., 89, 196–208 (1978). 161 M. S. Gold, D. E. Redmond, and H. D. Kleber, Lancet, 2, 599–602 (1978). 162 H. A. Sternbach, W. Annitto, A. L. C. Pottash, and M. S. Gold, Lancet, 1, 388–389 (1982). Citing Literature Volume2, Issue3July/September 1982Pages 211-246 ReferencesRelatedInformation

Referência(s)